Maria Cristina Gonzalez-Vazquez

Dr. Maria Cristina Gonzalez-Vazquez

Benemérita Universidad Autónoma de Puebla, Puebla City, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in Life
Verified
Journal Article
Open access
PDF file
Alejandro Díaz HernándezAlejandro Díaz Hernández
Alejandro Díaz Hernández
MGMaria Cristina Gonzalez-Vazquez
Maria Cristina Gonzalez-Vazquez
MAMinerva Arce-Fonseca
Minerva Arce-Fonseca
OROlivia Rodríguez-Morales
Olivia Rodríguez-Morales
LRLilia Cedillo Ramírez
Lilia Cedillo Ramírez
ACAlejandro Carabarin-Lima
Alejandro Carabarin-Lima
There is currently no vaccine against American trypanosomiasis, caused by the parasite Trypanosoma cruzi. This is due to the genomic variation observed in the six DTUs of T. cruzi. This work aims to propose a consensus sequence of the enolase protein from different strains of T. cruzi and mainly evaluate its immunogenic properties at the bioinformatic level. From specialized databases, 15 sequences of the enolase gene were aligned to obtain a consensus sequence, where this sequence was modeled and then evaluated and validated through different bioinformatic programs to learn their immunogenic potential. Finally, chimeric peptides were designed with the most representative epitopes. The results showed high immunogenic potential with six epitopes for MHC-I, and seven epitopes for MHC-II, all of which were highly representative of the enolase present in strains from the American continent as well as five epitopes for B cells. Regarding the computational modeling, molecular docking with Toll-like receptors showed a high affinity and low constant of dissociation, which could lead to an innate-type immune response that helps to eliminate the parasite. In conclusion, the consensus sequence proposed for enolase is capable of providing an ideal immune response; however, the experimental evaluation of this enolase consensus and their chimeric peptides should be a high priority to develop a vaccine against Chagas disease.

Verified
Journal Article
Open access
PDF file
YOYesenia Osorio-Aguilar
Yesenia Osorio-Aguilar
MGMaria Cristina Gonzalez-Vazquez
Maria Cristina Gonzalez-Vazquez
PLPatricia Lozano
Patricia Lozano
YMYgnacio Martinez-Laguna
Ygnacio Martinez-Laguna
LBLidia Baylon-Pacheco
Lidia Baylon-Pacheco
RRRosa del Carmen Rocha-Gracia
Rosa del Carmen Rocha-Gracia
Enolase proteins play a significant role as moonlighting proteins. In their role as surface-associated enolase, they have multiple functions as they interact with extracellular matrix proteins. Type I and III collagens are the major constituents of this extracellular matrix, and collagen is one of the targets of interaction with the enolase of many pathogens, thereby helping the colonization process and promoting the subsequent invasion of the host. This work aimed to determine the participation of non-typeable H. influenzae enolase as a collagen-binding protein. In this study, through the use of in vitro tests it was demonstrated that recombinant enolase of non-typeable H. influenzae (rNTHiENO) strongly binds to type I collagen. Using molecular docking, the residues that could take part in the interaction of non-typeable H. influenzae enolase-type I collagen (NTHiENO-Cln I) and non-typeable H. influenzae enolase-type III collagen (NTHiENO-Cln III) were identified. However, in vitro assays show that NTHiENO has a better affinity to interact with Cln I, concerning type Cln III. The interaction of NTHiENO with collagen could play a significant role in the colonization process; this would allow H. influenzae to increase its virulence factors and strengthen its pathogenesis.